Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Safe Orthopaedics Appoints Chief Financial Officer - Orthopedic Design & Technology
OEM News, People News

Safe Orthopaedics Appoints Chief Financial Officer

New hire has 13 years of experience in finance.

Safe Orthopaedics, a company offering ranges of sterile implants combined with their single-use instruments for back surgery, has appointed François-Henri Reynaud as chief financial and administrative officer.
 
Reynaud has 13 years’ experience in finance. For five years, he was initially involved in financing business companies in a financial institution, before overseeing several corporate finance transactions (fund-raising transactions, mergers and acquisitions) as chief financial and administrative officer of companies in a variety of sectors including medical devices and renewable energies. His most recent appointment was at Global Bioenergies, a listed industrial biology company.

Reynaud’s main role will be to handle the company’s financial and administrative affairs, working closely with the CEO.
 
“It is a unique opportunity to join Safe Orthopaedics just as the company has reported an increase in its third-quarter revenues of over 63 percent year-on-year and is expanding its business worldwide,” Reynaud said.
 
“Together with his expertise in finance, François-Henri’s appointment as chief financial and administrative officer brings to the table his experience of establishing and building up international subsidiaries just as Safe Orthopaedics embarks on a new phase of expansion to accelerate its growth and business development,” CEO Pierre Dumouchel added.
 
Founded in 2010, Safe Orthopaedics is a French medical technology company that develops spinal implants and associated single-use instruments. Through this approach, these products eliminate all risk of contamination, reduce infection risks and facilitate a minimally-invasive approach for trauma and degenerative pathologies—benefiting patients. Protected by 17 patent families, the SteriSpineTM kits are CE-marked and approved by the U.S. Food and Drug Administration. The company is based at Eragny-sur-Oise (Val d’Oise department), and has 34 employees.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters